0000899243-22-027631.txt : 20220803 0000899243-22-027631.hdr.sgml : 20220803 20220803174808 ACCESSION NUMBER: 0000899243-22-027631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220801 FILED AS OF DATE: 20220803 DATE AS OF CHANGE: 20220803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chung Wendy CENTRAL INDEX KEY: 0001922605 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40693 FILM NUMBER: 221133913 MAIL ADDRESS: STREET 1: PRIME MEDICINE, INC. STREET 2: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rallybio Corp CENTRAL INDEX KEY: 0001739410 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851083789 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 234 CHURCH STREET STREET 2: SUITE 1020 CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203- 859-3820 MAIL ADDRESS: STREET 1: 234 CHURCH STREET STREET 2: SUITE 1020 CITY: NEW HAVEN STATE: CT ZIP: 06510 FORMER COMPANY: FORMER CONFORMED NAME: Rallybio Holdings, LLC DATE OF NAME CHANGE: 20180502 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-01 0 0001739410 Rallybio Corp RLYB 0001922605 Chung Wendy C/O RALLYBIO CORPORATION 234 CHURCH STREET, SUITE 1020 NEW HAVEN CT 06510 1 0 0 0 Option (Right to Buy) 9.11 2022-08-01 4 A 0 26880 0.00 A 2032-08-01 Common Stock 26880 26880 D The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in three equal annual installments beginning on August 1, 2023. /s/ Michael Greco, Attorney-in-Fact 2022-08-03